TrialSignal
Clinical trial intelligence report
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT05326750-Jul 28, 2026
NCT ID
NCT05326750
Status
RECRUITING
Phase
NA
Sponsor
Kuopio University Hospital
Executive brief
Investment-Ready Snapshot
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases is a NA clinical asset sponsored by Kuopio University Hospital in Alzheimer Disease, Frontotemporal Dementia, Dementia With Lewy Bodies. SEO and diligence focus: Gamma tACS (40 Hz) over the superior parietal cortex, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05326750
Indication
Alzheimer Disease
Modality
medical device
Target
Gamma tACS (40 Hz) over the superior parietal cortex
Intervention
Gamma tACS (40 Hz) over the superior parietal cortex
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.